Salipro invited to speak at the GPCRs-Targeted Drug Discovery Summit

Salipro Biotech will be presenting at the 3rd GPCRs-Targeted Drug Discovery Summit (March 5-7) in Boston with our CSO, Robin Löving, as an invited speaker.

Save the date and join us on Wednesday, March 6, as Robin takes the stage to present the latest advancements on the Salipro® platform for the discovery of novel therapeutics against GPCRs. 

Conference information


Previous
Previous

Salipro Biotech to present at Oxford Global Biologics 2024

Next
Next

Salipro Biotech announces multi-target research collaboration with an additional Top5 crop protection company